Water Island Capital LLC Paratek Pharmaceuticals, Inc. Transaction History

Water Island Capital LLC

$908 Million
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Nov 14, 2024	BUY	$1.52 - $2.8 $91,499 - $168,551	60,197 Added 245.7%	84,697 $187,000
Q2 2023 Aug 14, 2023	BUY	$1.52 - $2.8 $108,903 - $200,611	71,647 Added 549.02%	84,697 $187,000
Q1 2023 Nov 14, 2024	SELL	$1.37 - $2.54 $34,263 - $63,525	-25,010 Reduced 50.52%	24,500 $62,000
Q1 2023 May 25, 2023	SELL	$1.37 - $2.54 $34,263 - $63,525	-25,010 Reduced 65.71%	13,050 $33,000
Q4 2022 Nov 14, 2024	BUY	$1.67 - $2.51 $82,681 - $124,270	49,510 New	49,510 $92,000
Q4 2022 Feb 14, 2023	SELL	$1.67 - $2.51 $19,121 - $28,739	-11,450 Reduced 23.13%	38,060 $71,000
Q3 2022 Nov 14, 2022	BUY	$1.96 - $2.93 $1,025 - $1,532	523 Added 1.07%	49,510 $127,000
Q2 2022 Aug 15, 2022	SELL	$1.73 - $3.09 $10,174 - $18,172	-5,881 Reduced 10.72%	48,987 $95,000
Q1 2022 May 13, 2022	SELL	$2.94 - $4.77 $3,245 - $5,266	-1,104 Reduced 1.97%	54,868 $163,000
Q4 2021 Feb 14, 2022	BUY	$4.07 - $5.3 $50,370 - $65,592	12,376 Added 28.39%	55,972 $251,000
Q3 2021 Nov 12, 2021	BUY	$4.7 - $7.24 $45,825 - $70,590	9,750 Added 28.81%	43,596 $212,000
Q2 2021 Aug 12, 2021	BUY	$6.81 - $10.93 $230,491 - $369,936	33,846 New	33,846 $231,000
Q1 2021 May 13, 2021	SELL	$6.14 - $8.31 $484,194 - $655,318	-78,859 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$4.58 - $7.14 $671,199 - $1.05 Million	-146,550 Reduced 65.02%	78,859 $494,000
Q3 2020 Nov 12, 2020	SELL	$4.19 - $6.69 $379,798 - $606,408	-90,644 Reduced 28.68%	225,409 $1.22 Million
Q2 2020 Aug 12, 2020	SELL	$2.97 - $5.22 $106,587 - $187,335	-35,888 Reduced 10.2%	316,053 $1.65 Million
Q1 2020 May 12, 2020	SELL	$2.67 - $4.97 $178,195 - $331,697	-66,740 Reduced 15.94%	351,941 $1.11 Million
Q4 2019 Feb 11, 2020	SELL	$2.93 - $4.5 $38,215 - $58,693	-13,043 Reduced 3.02%	418,681 $1.69 Million
Q3 2019 Nov 12, 2019	BUY	$3.08 - $5.76 $79,411 - $148,510	25,783 Added 6.35%	431,724 $1.87 Million
Q2 2019 Aug 12, 2019	BUY	$3.47 - $6.32 $136,346 - $248,331	39,293 Added 10.72%	405,941 $1.62 Million
Q1 2019 May 03, 2019	BUY	$5.36 - $7.24 $257,976 - $348,461	48,130 Added 15.11%	366,648 $1.97 Million
Q4 2018 Feb 05, 2019	SELL	$4.8 - $11.6 $581,798 - $1.41 Million	-121,208 Reduced 27.56%	318,518 $1.63 Million
Q3 2018 Nov 13, 2018	BUY	$9.05 - $10.95 $1.39 Million - $1.68 Million	153,226 Added 53.48%	439,726 $4.27 Million
Q2 2018 Aug 09, 2018	BUY	$10.2 - $13.9 $306,000 - $417,000	30,000 Added 11.7%	286,500 $2.92 Million
Q1 2018 May 14, 2018	BUY	$12.65 - $18.85 $948,750 - $1.41 Million	75,000 Added 41.32%	256,500 $3.34 Million
Q4 2017 Feb 13, 2018	BUY	$17.45 - $25.6 $1.48 Million - $2.18 Million	85,000 Added 88.08%	181,500 $3.25 Million
Q3 2017 Nov 14, 2017	BUY	$18.9 - $28.2 $1.82 Million - $2.72 Million	96,500	96,500 $2.42 Million

Others Institutions Holding PRTK

# of Institutions

Shares Held

1.54M

Call Options Held

Put Options Held

View Full List

About Paratek Pharmaceuticals, Inc.

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

More about PRTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Water Island Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Water Island Capital LLC with notifications on news.

Account